A Phase II Study of Acute Toxicity for Celebrex™ (Celecoxib) and Chemoradiation in Patients With Locally Advanced Cervical Cancer: Primary Endpoint Analysis of RTOG 0128
International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2006.08.002
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2007
Authors
Publisher
Elsevier BV